This workstream is to address the utility of guidelines for Salivary Gland Cancers (SGC)

There are no 'complete' guidelines fit for SGC currently, in the UK.  There are existing generic guidelines that may cover an aspect of SGCs or guidelines may miss a specific SGC component. 

Existing international guidelines differ in some aspects e.g. ESMO and ASCO.

From the patient perspective they can feel they are 'going in for a fight' each time when planning treatment or follow ups as there are disparate views. 

Disparate views in treatment planning and follow ups can extend to MDTs.

 

Workstream Lead:

Emma Kinloch - Interim lead

 

Workstream Members:

Sarah Brigham

Dr Satya Garikipati

Dr Puteri Abdul Haris

Dr Michael Ho

Will Ince

Professor Ali Khurram

Romelie Rieu 

 

 

For expressions of interest, or any other questions about this workstream please contact [email protected]